Page 265 - Pagetit
P. 265

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE




                   Chapter 7 and below, there are important ethical considerations in any such
                   genetic screening or preventive immunotherapy.
                     With respect to treatment strategies deriving from neuroscience research,
                   immunotherapies could also presumably be applied to cases coming to
                   treatment. Future developments in neuroscience may produce genetic
                   modifications which would alter susceptibility to use of or dependence on
                   particular classes of substances, though such developments presently seem
                   quite far in the future.
                     Apart from the above, there seem to be two main choices in terms of
                   biological interventions. Both of these are already on the scene, and the main
                   pay-off from the neuroscience research is likely to be in improvements in the
                   particular medication or formulation used. The first choice is the use of
                   medications or procedures which interfere in one way or another with the
                   action of the substance in the body, taking away the positive rewards from
                   using the substance or making its use aversive. Such medications have been
                   in use for more than half a century. Extensive experience suggests that the
                   main problem with these interventions is lack of patient compliance, where
                   those with a history of extensive use of a substance often prove unable to
                   keep to any commitment they have made to continual use of the antagonist
                   or aversive substance.
                     The other choice is the use of substances which are wholly or partially agonists,
                   replacing the problematic substance or mode of administration with another
                   which produces at least some of the same biological and experiential effects.
                   This choice has been most widely explored and used for opioids, with codeine,
                   methadone, buprenorphine and other substances substituting for heroin or
                   other opiates. Nicotine replacement therapy, which substitutes for cigarettes, is
                   now widely used thereby eliminating most of the public health harm.

                   Ethical issues in the application of the neuroscience findings
                   In the broadest sense, ethical issues have always been important in the use
                   of psychoactive substances, and in societal responses to their use. Whether
                   they should be used at all continues to be a contentious issue. Thus, for
                   instance, Islam and some branches of other major world religions forbid the
                   use of alcohol to faithful adherents. Ethical judgements are written into the
                   major international drug control conventions (see Box 1.1). On the other
                   hand, arguments against the criminalization of substance use are also
                   frequently couched in ethical terms (e.g. Husak, 2002).
                     Within the somewhat narrower frame of ethics in health and human
                   services, research and interventions, Chapter 7 has considered in some detail
                   many of the ethical issues which are relevant to neuroscience research and
                   the application of its findings. Only a few of these are emphasized here, with
                   particular reference to their potential applications mentioned above.
                     Perhaps the most urgent ethical considerations arise around the issue
                   of genetic screening, which is already on the horizon. A person identified


                                                  244




          Chapter_8                244                             19.1.2004, 11:51
   260   261   262   263   264   265   266   267   268   269   270